394 related articles for article (PubMed ID: 17713111)
1. [Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
Valikovics A
Ideggyogy Sz; 2007 Jul; 60(7-8):301-10. PubMed ID: 17713111
[TBL] [Abstract][Full Text] [Related]
2. [Study of the effects of vinpocetin on cognitive functions].
Valikovics A; Csányi A; Németh L
Ideggyogy Sz; 2012 Mar; 65(3-4):115-20. PubMed ID: 23136730
[TBL] [Abstract][Full Text] [Related]
3. Transcranial Doppler assessment of cerebral vasomotor reactivity in evaluating the effects of vinpocetine in cerebral small vessel disease: a pilot study.
Jovanović ZB; Pavlović AM; Pekmezović T; Mijajlović M; Covicković NS
Ideggyogy Sz; 2013 Jul; 66(7-8):263-8. PubMed ID: 23971358
[TBL] [Abstract][Full Text] [Related]
4. [The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Bagoly E; Fehér G; Szapáry L
Orv Hetil; 2007 Jul; 148(29):1353-8. PubMed ID: 17631470
[TBL] [Abstract][Full Text] [Related]
5. [The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
Horváth S
Orv Hetil; 2001 Feb; 142(8):383-9. PubMed ID: 11263076
[TBL] [Abstract][Full Text] [Related]
6. Role of vinpocetine in cerebrovascular diseases.
Patyar S; Prakash A; Modi M; Medhi B
Pharmacol Rep; 2011; 63(3):618-28. PubMed ID: 21857073
[TBL] [Abstract][Full Text] [Related]
7. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.].
Solovyeva EY; Karneev AN; Chekanov AV; Baranova OA; Choi IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):103-108. PubMed ID: 28638040
[TBL] [Abstract][Full Text] [Related]
8. [Vinpocetin in neurological diseases].
Szapáry L; Késmárky G; Tóth K; Misnyovszky M; Tóth T; Balogh A; Nagy K; Németh GY; Fehér G
Ideggyogy Sz; 2012 Nov; 65(11-12):387-93. PubMed ID: 23289173
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.
Zhang W; Huang Y; Li Y; Tan L; Nao J; Hu H; Zhang J; Li C; Kong Y; Song Y
Clin Drug Investig; 2016 Sep; 36(9):697-704. PubMed ID: 27283947
[TBL] [Abstract][Full Text] [Related]
10. [The effect of a single-dose intravenous vinpocetine on brain metabolism in patients with ischemic stroke].
Gulyás B; Bönöczk P; Vas A; Csiba L; Bereczki D; Boros I; Szakáll S; Balkay L; Emri M; Fekete I; Galuska L; Kerényi L; Lehel S; Márián T; Molnár T; Varga J; Trón L
Orv Hetil; 2001 Mar; 142(9):443-9. PubMed ID: 11301903
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of vinpocetine against brain damage caused by ischemia.
Rischke R; Krieglstein J
Jpn J Pharmacol; 1991 Jul; 56(3):349-56. PubMed ID: 1895579
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic ischemic cerebrovascular disorders and neuroprotection with vinpocetine.
Hadjiev D
Ideggyogy Sz; 2003 May; 56(5-6):166-72. PubMed ID: 12861957
[TBL] [Abstract][Full Text] [Related]
13. Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study.
Bönöczk P; Panczel G; Nagy Z
Eur J Ultrasound; 2002 Jun; 15(1-2):85-91. PubMed ID: 12044859
[TBL] [Abstract][Full Text] [Related]
14. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
Szilágyi G; Nagy Z; Balkay L; Boros I; Emri M; Lehel S; Márián T; Molnár T; Szakáll S; Trón L; Bereczki D; Csiba L; Fekete I; Kerényi L; Galuska L; Varga J; Bönöczk P; Vas A; Gulyás B
J Neurol Sci; 2005 Mar; 229-230():275-84. PubMed ID: 15760651
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cavinton forte on the cerebral hemodynamic and autoregulation mechanisms of cerebral blood flow in patients with chronic cerebral ischemia].
Grigor'eva AN; Nesterova MV
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):90-1. PubMed ID: 19708280
[No Abstract] [Full Text] [Related]
16. [Vinpotropile in the treatment of cerebral vascular diseases].
Filimonov VA; Kliueva VN; Kondrasheva IN
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000
[No Abstract] [Full Text] [Related]
17. Vinpocetine. Monograph.
Altern Med Rev; 2002 Jun; 7(3):240-3. PubMed ID: 12126465
[No Abstract] [Full Text] [Related]
18. Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients.
Kemény V; Molnár S; Andrejkovics M; Makai A; Csiba L
J Clin Pharmacol; 2005 Sep; 45(9):1048-54. PubMed ID: 16100299
[TBL] [Abstract][Full Text] [Related]
19. [An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
Vaizova OE; Vengerovskiĭ AI; Alifirova VM
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; Suppl 16():46-50. PubMed ID: 18196635
[TBL] [Abstract][Full Text] [Related]
20. [Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
Szapáry L; Horváth B; Alexy T; Márton Z; Késmárky G; Szóts M; Nagy F; Czopf J; Tóth K
Orv Hetil; 2003 May; 144(20):973-8. PubMed ID: 12830727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
